NIQ, which is majority owned by private-equity firm Advent International, late Tuesday said it is selling 50 million shares at $21 apiece in the IPO, compared with an expected price range of $20 to ...

Carlsmed will have more than 27.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization of nearly $413 million at the $15-a-share ...